Skip to main content
. 2020 Nov 23;10:601055. doi: 10.3389/fonc.2020.601055

Figure 1.

Figure 1

lncRNA AFAP1-AS1 is a marker for poor prognostic outcomes in NPC patients. (A) AFAP1-AS1 expression in NPC cells and nasopharyngeal epithelial cells. (B) Compared with paired nontumor specimens, AFAP1-AS1 expression is upregulated in freshly frozen NPC tumor tissues. (C) Representative images of AFAP1-AS1 expression in paraffin-embedded NPC tumors and paired adjacent nontumor specimens detected using RNAscope. Scale bars: 50 µm. (D) Quantification of AFAP1-AS1 expression in (C). (E) Kaplan-Meier analysis of overall survival (OS) in NPC patients with high vs. low AFAP1-AS1 expression. (F, G) AFAP1-AS1 is expressed in both the nucleus and cytoplasm of NPC cells as detected using qRT-PCR. Error bars represent the standard deviation for each value. *P < 0.05. ***P < 0.001. The data represent three independent experiments. lncRNA, long noncoding RNA.